These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2062229)

  • 1. Iteration of hybridoma growth and productivity in hollow fiber bioreactors using 31P NMR.
    Gillies RJ; Scherer PG; Raghunand N; Okerlund LS; Martinez-Zaguilan R; Hesterberg L; Dale BE
    Magn Reson Med; 1991 Mar; 18(1):181-92. PubMed ID: 2062229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale production of murine monoclonal antibodies using hollow fiber bioreactors.
    Evans TL; Miller RA
    Biotechniques; 1988 Sep; 6(8):762-7. PubMed ID: 3273638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nuclear magnetic resonance technique for determining hybridoma cell concentration in hollow fiber bioreactors.
    Mancuso A; Fernandez EJ; Blanch HW; Clark DS
    Biotechnology (N Y); 1990 Dec; 8(12):1282-5. PubMed ID: 1366962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of simple growth vessels and a specially designed bioreactor for the cultivation of hybridoma cells.
    Persson B; Emborg C
    Cytotechnology; 1992; 8(3):179-87. PubMed ID: 1368814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximisation of perfusion systems and process comparison with batch-type cultures. Maximisation of perfusion cultures.
    Griffiths JB; Looby D; Racher AJ
    Cytotechnology; 1992; 9(1-3):3-9. PubMed ID: 1369179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
    Chen Y
    Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative flow measurements in bioreactors by nuclear magnetic resonance imaging.
    Hammer BE; Heath CA; Mirer SD; Belfort G
    Biotechnology (N Y); 1990 Apr; 8(4):327-30. PubMed ID: 1366461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and isolation of cells for optimal growth in hollow fiber bioreactors.
    Gramer MJ; Britton TL
    Hybridoma; 2000 Oct; 19(5):407-12. PubMed ID: 11128030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the evaluation of gas-liquid interfacial effects on hybridoma viability in bubble column bioreactors.
    Handa A; Emery AN; Spier RE
    Dev Biol Stand; 1987; 66():241-53. PubMed ID: 3582753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale culture of hybridoma and mammalian cells in fluidized bed bioreactors.
    Dean RC; Karkare SB; Ray NG; Runstadler PW; Venkatasubramanian K
    Ann N Y Acad Sci; 1987; 506():129-46. PubMed ID: 3324851
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of extracellular glutamine concentration on primary and secondary metabolism of a murine hybridoma: an in vivo 13C nuclear magnetic resonance study.
    Mancuso A; Sharfstein ST; Fernandez EJ; Clark DS; Blanch HW
    Biotechnol Bioeng; 1998 Jan; 57(2):172-86. PubMed ID: 10099192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
    Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
    J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified CelliGen-packed bed bioreactors for hybridoma cell cultures.
    Wang G; Zhang W; Jacklin C; Freedman D; Eppstein L; Kadouri A
    Cytotechnology; 1992; 9(1-3):41-9. PubMed ID: 1369180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive control of hollow-fiber bioreactors for the production of monoclonal antibodies.
    Dowd JE; Weber I; Rodriguez B; Piret JM; Kwok KE
    Biotechnol Bioeng; 1999 May; 63(4):484-92. PubMed ID: 10099629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
    Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of metabolic parameters and optimization of antibody production using high cell density hybridoma in hollow fiber bioreactors.
    Liu CH; Liu YX; Kumari M; Wu WC
    Biotechnol Lett; 2019 Sep; 41(8-9):963-977. PubMed ID: 31325004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreactor for blood product production.
    Doran MR; Aird IA; Marturana F; Timmins N; Atkinson K; Nielsen LK
    Cell Transplant; 2012; 21(6):1235-44. PubMed ID: 22405378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.
    Tapia F; Vogel T; Genzel Y; Behrendt I; Hirschel M; Gangemi JD; Reichl U
    Vaccine; 2014 Feb; 32(8):1003-11. PubMed ID: 24269322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineering analysis of rotating sieves for hybridoma cell retention in stirred tank bioreactors.
    Favre E; Thaler T
    Cytotechnology; 1992; 9(1-3):11-9. PubMed ID: 1369163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.